We provide patients across our markets with 760+ high-quality and affordable medicines.
We manufacture and bring patients across North America, MENA and Europe a broad range of injectable and oral generics, branded generics, specialty and branded pharmaceutical and compounded products.
Our products are approved in different countries for specific uses and the information we provide is governed by local laws and regulations.
Please visit our local Hikma websites to find out more about our products in your country of residence. Always ask a healthcare professional for advice about medicines.
To report an adverse event please contact us at pv@hikma.com
or alternatively use our country specific contact details:
Algeria. pharmacovigilanceAlgerie@hikma.com
Canada. Canada_DrugSafety@hikma.com
Egypt. PVEgypt@hikma.com
France. francepv@hikma.com
Germany. dl-muc-qs@hikma.com
Iraq.pv@hikma.com
Italy. portugaleupharmacovigilance@hikma.com or call +351 939 610 004
Jordan. pv@hikma.com
KSA. SAPV@hikma.com
Morocco.MAPV@Hikma.com
Portugal. portugaleupharmacovigilance@hikma.com or call +351 939 610 004
Spain. espana@hikma.com
The Netherlands. beneluxqapv@hikma.com
Tunisia. pv@hikma.com
US. us.hikma@primevigilance.com or call +1-877-845-0689 or 1-800-962-8364, or you can contact the FDA directly at 1-800-FDA-1088 or www.fda.gov/medwatch
Explore more
Number of products as of February 2024